HHS advisory panel recommends new directions in federal oversight of genetic testing: see the Focus
—New draft report to the HHS Secretary released for comment
—General advice to HHS
—CMS urged to strengthen CLIA oversight, including development of proficiency testing or robust alternatives
—FDA urged to take broad consultative approach to regulating lab-developed tests
—Coverage and reimbursement gap
—Regulatory status of currently available genetic tests
—Oversight at the state level
Medicare Claims Advisory: January 1 is key NPI deadline
Medicare continues to reduce improper claims payments
Washington Watch: Waiting for Medicare’s final 2008 lab fee schedule

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

December 17, 2007 - Table of Contents

NIR December 17, 2007 (full PDF issue)

CMS Forging Ahead with Lab Bidding Demo in San Diego

Time Running Out for Physician Fee Fix

Advisory Panel Prescribes Changes for CMS, FDA in Genetic Test Oversight

January 1—Key Deadline for Use of National Provider Identifier

Medicare Improper Claims Payment Continues to Drop